New review paper published in 'Oncogene' (20/09/2026)
GBM remains one of the hardest cancers to treat, and conventional models still fail to capture the full complexity of the human immune–tumour crosstalk and CNS barriers. This review maps how humanised mouse models are helping bridge that gap. A valuable resource for GBM immunology and preclinical model design.
Comments